Antibiotic Residues in Final Effluents of European Wastewater Treatment

Total Page:16

File Type:pdf, Size:1020Kb

Antibiotic Residues in Final Effluents of European Wastewater Treatment Environment International 140 (2020) 105733 Contents lists available at ScienceDirect Environment International journal homepage: www.elsevier.com/locate/envint Antibiotic residues in final effluents of European wastewater treatment plants and their impact on the aquatic environment T ⁎ Sara Rodriguez-Mozaza,b, , Ivone Vaz-Moreirac, Saulo Varela Della Giustinaa,b, Marta Llorcaa,b,d, Damià Barcelóa,b,d, Sara Schuberte, Thomas U. Berendonke, Irene Michael-Kordatouf, Despo Fatta-Kassinosf,g, Jose Luis Martinezh, Christian Elpersi, Isabel Henriquesj, Thomas Jaegerk, Thomas Schwartzk, Erik Paulshusl, Kristin O'Sullivanl, Katariina M.M. Pärnänenm, Marko Virtam, Thi Thuy Don, Fiona Walshn, Célia M. Manaiac a Catalan Institute for Water Research (ICRA), Emili Grahit 101, 17003 Girona, Spain b Universitat de Girona, Girona, Spain c Universidade Católica Portuguesa, CBQF – Centro de Biotecnologia e Química Fina – Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal d Water and Soil Quality Research Group, Department of Environmental Chemistry, (IDAEA-CSIC), Jordi Girona 18-26, 08034, Barcelona, Spain e Technische Universität Dresden, Institute of Hydrobiology, Dresden, Germany f Nireas-International Water Research Centre, University of Cyprus, P.O. Box 20537, CY-1678 Nicosia, Cyprus g Department of Civil and Environmental Engineering, University of Cyprus, P.O. Box 20537, CY-1678 Nicosia, Cyprus h Centro Nacional de Biotecnología, CSIC, Darwin 3, 20049 Madrid. Spain i Aquantec GmbH, Am Zwinger 5, 76227 Karlsruhe, Germany j Centre for Environmental and Marine Studies (CESAM, University of Aveiro) and Department of Life Sciences, Faculty of Sciences and Technology, University of Coimbra, Calçada Martin de Freitas, 3000-456 Coimbra, Portugal k Karlsruhe Institute of Technology (KIT) – Campus North, Institute of Functional Interfaces (IFG), P.O. Box 3640, 76021 Karlsruhe, Germany l Norwegian University of Life Sciences, Faculty of Veterinary Medicine, Department of Food Safety and Infection Biology, Section of Microbiology, Immunology and Parasitology, Post Box 8146 Dep., 0033 Oslo, Norway m Department of Microbiology, University of Helsinki, Viikinkaari 9, 00014 University of Helsinki, Finland n Department of Biology, Maynooth University, Maynooth, Co. Kildare, Ireland ARTICLE INFO ABSTRACT Handling Editor: Adrian Covaci A comprehensive monitoring of a broad set of antibiotics in the final effluent of wastewater treatment plants (WWTPs) of 7 European countries (Portugal, Spain, Ireland, Cyprus, Germany, Finland, and Norway) was carried out in two consecutive years (2015 and 2016). This is the first study of this kind performed at an international level. Within the 53 antibiotics monitored 17 were detected at least once in the final effluent of the WWTPs, i.e.: ciprofloxacin, ofloxacin, enrofloxacin, orbifloxacin, azithromycin, clarithromycin, sulfapyridine, sulfamethox- azole, trimethoprim, nalidixic acid, pipemidic acid, oxolinic acid, cefalexin, clindamycin, metronidazole, am- picillin, and tetracycline. The countries exhibiting the highest effluent average concentrations of antibiotics were Ireland and the southern countries Portugal and Spain, whereas the northern countries (Norway, Finland and Germany) and Cyprus exhibited lower total concentration. The antibiotic occurrence data in the final effluents were used for the assessment of their impact on the aquatic environment. Both, environmental predicted no effect concentration (PNEC-ENVs) and the PNECs based on minimal inhibitory concentrations (PNEC-MICs) were considered for the evaluation of the impact on microbial communities in aquatic systems and on the evolution of antibiotic resistance, respectively. Based on this analysis, three compounds, ciprofloxacin, azithromycin and cefalexin are proposed as markers of antibiotic pollution, as they could occasionally pose a risk to the en- vironment. Integrated studies like this are crucial to map the impact of antibiotic pollution and to provide the basis for designing water quality and environmental risk in regular water monitoring programs. ⁎ Corresponding author at: Catalan Institute for Water Research (ICRA), Scientific and Technologic Park of the University of Girona, Emili Grahit 101, E-17003 Girona, Spain. E-mail address: [email protected] (S. Rodriguez-Mozaz). https://doi.org/10.1016/j.envint.2020.105733 Received 27 December 2019; Received in revised form 16 March 2020; Accepted 8 April 2020 Available online 27 April 2020 0160-4120/ © 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/). S. Rodriguez-Mozaz, et al. Environment International 140 (2020) 105733 1. Introduction Spain, Ireland, Cyprus, Germany, Finland, and Norway) was sampled twice (early Spring and early Autumn) in two consecutive years (2015 Antibiotics are a class of pharmaceutical active compounds with and 2016) and was monitored for 53 antibiotic residues belonging to 10 high usage and consumption worldwide. By definition, an antibiotic is a different therapeutic classes. The countries were selected following a chemotherapeutic agent that specifically inhibits, by cell destruction or north-to-south gradient in the use of antibiotics as well as in the pre- growth inhibition, the proliferation of bacteria (Kümmerer, 2009). valence of antibiotic resistance in clinical settings as reported in the According to Kümmerer (2009) over 250 different chemical substances 2017 EARS-Net surveillance report (ECDC European Centre for Disease are registered as antibiotics for human and/or animal health use Prevention and Control, 2017). The specific objectives of the study globally. Based on the analysis of data from scientific literature and were: (i) to provide an overview of the presence and concentration of national and regional surveillance systems from 71 countries over the antibiotics in final effluents of WWTPs located in different European past 10 years, antibiotic use is growing steadily worldwide (30%), countries; (ii) to assess geographical and temporal trends about the driven mainly by rising demand in low- and middle-income countries occurrence of these contaminants; (iii) to infer about the potential en- (Gelband et al. 2015). This increase in the use of antibiotics and the vironmental and human health risk posed by antibiotic residues in final awareness about their side effects have led to increasing concern re- treated wastewater effluents; and (iv) to propose robust analytical tools garding their potentially detrimental effects in the environment. In and indicator compounds to be used in regular water-monitoring pro- particular, it is suspected that their occurrence can accelerate resistance grams, hence making feasible the comparison of country-based studies. spread in the environment (Bengtsson-Palme et al., 2018), with po- tential implications on human health. According to the World Health 2. Materials and methods Organization (WHO), antimicrobial resistance is a major challenge to global human and animal health, food safety, and development today, 2.1. Sampling campaigns with the perspective of aggravation in the upcoming years, if effective measures are not implemented (World Health Organization, 2014). Four sampling campaigns were carried out in early Spring (March Because of the intensive use of antibiotics for human, veterinary and 2015 and 2016) and early Autumn (October 2015 and September agriculture purposes, these compounds are continuously released into 2016), suggested to correspond to the highest and the lowest peaks of the environment from anthropogenic sources. In urban areas, waste- antibiotic consumption, respectively (Caucci et al., 2016; Sun et al., water treatment plants (WWTPs), when available, are among the main 2012). In each of the 4 sampling campaigns, 24-h composite samples receptors of antibiotics, part of which persist after the treatment and were collected in 3 consecutive days (Tuesday, Wednesday, and can be released into various environmental compartments (Michael Thursday) at the outlet of 13 urban WWTPs belonging to 7 European et al., 2013). Several studies about the presence of antibiotics in countries (Portugal, Spain, Cyprus, Ireland, Germany, Finland, and WWTPs have been conducted in the last couple of decades. Most of Norway) (Fig. 1, Table S1). Two WWTPs were monitored in each them have focused on a limited amount of compounds (between 2 and country except in Spain and Norway, where a single WWTP was sam- 33 target antibiotics). Further, studies comparing the situation in dif- pled. In Portugal, due to a problem in the WWTP PT1 in the sampling ferent countries are nearly absent and, in the case that a single country campaign of March 2016, a third WWTP (PT3), located in the same as China, Croatia, Sweden, Portugal, United Kingdom, and Greece is region, was sampled instead. General characteristics of the selected analysed, a limited number of WWTPs, varying between 2 and 19 WWTPs are gathered in Table S2. For every campaign, data concerning within each country has been studied (Gao et al., 2012; Johnson et al., weather conditions were collected for the 3 days of sampling and the 2017; Kosma et al., 2014; Lindberg et al., 2005; Pereira et al., 2015; day before (Table S3). Senta et al., 2013; Wang et al., 2018; Zhang et al., 2019). Among the All participants collected the samples on the same dates and most comprehensive studies so far are those by Gracia-Lor et al. (2011), adopted a common protocol for sampling
Recommended publications
  • Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications
    International Journal of Molecular Sciences Review Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications Daniel Fernández-Villa 1, Maria Rosa Aguilar 1,2 and Luis Rojo 1,2,* 1 Instituto de Ciencia y Tecnología de Polímeros, Consejo Superior de Investigaciones Científicas, CSIC, 28006 Madrid, Spain; [email protected] (D.F.-V.); [email protected] (M.R.A.) 2 Consorcio Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, 28029 Madrid, Spain * Correspondence: [email protected]; Tel.: +34-915-622-900 Received: 18 September 2019; Accepted: 7 October 2019; Published: 9 October 2019 Abstract: Bacterial, protozoan and other microbial infections share an accelerated metabolic rate. In order to ensure a proper functioning of cell replication and proteins and nucleic acids synthesis processes, folate metabolism rate is also increased in these cases. For this reason, folic acid antagonists have been used since their discovery to treat different kinds of microbial infections, taking advantage of this metabolic difference when compared with human cells. However, resistances to these compounds have emerged since then and only combined therapies are currently used in clinic. In addition, some of these compounds have been found to have an immunomodulatory behavior that allows clinicians using them as anti-inflammatory or immunosuppressive drugs. Therefore, the aim of this review is to provide an updated state-of-the-art on the use of antifolates as antibacterial and immunomodulating agents in the clinical setting, as well as to present their action mechanisms and currently investigated biomedical applications. Keywords: folic acid antagonists; antifolates; antibiotics; antibacterials; immunomodulation; sulfonamides; antimalarial 1.
    [Show full text]
  • Rifampicin/Cotrimoxazole/Isoniazid Versus Mefloquine Or Quinine Þ Sulfadoxine- Pyrimethamine for Malaria: a Randomized Trial
    PLoS CLINICAL TRIALS Rifampicin/Cotrimoxazole/Isoniazid Versus Mefloquine or Quinine þ Sulfadoxine- Pyrimethamine for Malaria: A Randomized Trial Blaise Genton1,2*, Ivo Mueller2, Inoni Betuela2, Gerard Casey2, Meza Ginny2, Michael P. Alpers2¤, John C. Reeder2 1 Swiss Tropical Institute, Basel, Switzerland, 2 Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea . ABSTRACT ............................................................................................................................................. Trial Registration: . Objectives: Previous studies of a fixed combination including cotrimoxazole, rifampicin, and ClinicalTrials.gov:NCT00322907 . isoniazid (Cotrifazid) showed efficacy against resistant strains of Plasmodium falciparum in . Funding: The study received . animal models and in small-scale human studies. We conducted a multicentric noninferiority financial support from Fatol . trial to assess the safety and efficacy of Cotrifazid against drug-resistant malaria in Papua New Arzneimittel GmbH, Germany. The . maintenance of the study site in the . Guinea. East Sepik Province was funded by . the Australian Agency for . Design: The trial design was open-label, block-randomised, comparative, and multicentric. International Development (AusAID) . grant to the Papua New Guinea . Institute of Medical Research. Fatol . Setting: The trial was conducted in four primary care health facilities, two in urban and two in Arzneimittel GmbH was able to . review and comment on the . rural areas of Madang and East Sepik Province, Papua New Guinea. protocol, and to review the study . conduct. The funders had no role in . study design, data collection and . Participants: Patients of all ages with recurrent uncomplicated malaria were included. analysis, decision to publish, or . preparation of the manuscript. Interventions: Patients were randomly assigned to receive Cotrifazid, mefloquine, or the . Competing Interests: The authors . standard treatment of quinine with sulfadoxine–pyrimethamine (SP).
    [Show full text]
  • Dietary Exposure Assessment of Veterinary Antibiotics in Pork Meat on Children and Adolescents in Cyprus
    foods Article Dietary Exposure Assessment of Veterinary Antibiotics in Pork Meat on Children and Adolescents in Cyprus Demetra Kyriakides 1,2,* , Andreas C. Lazaris 1, Konstantinos Arsenoglou 2, Maria Emmanouil 2, Olympia Kyriakides 3, Nikolaos Kavantzas 1 and Irene Panderi 4,* 1 Laboratory of Pathological Anatomy, Department of Clinical and Laboratory Medicine, School of Medicine, National and Kapodistrian University of Athens, 75, Mikras Asias Avenue, Goudi, 11527 Athens, Greece; [email protected] (A.C.L.); [email protected] (N.K.) 2 Veterinary Services, Ministry of Agriculture, Rural Development and Environment, 1417 Nicosia, Cyprus; [email protected] (K.A.); [email protected] (M.E.) 3 Archbishop Makarios III Hospital, 2012 Nicosia, Cyprus; [email protected] 4 Laboratory of Pharmaceutical Analysis, Panepistimiopolis, Division of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Zografou, 15771 Athens, Greece * Correspondence: [email protected] (D.K.); [email protected] (I.P.); Tel.: +30-210-727-4820 (I.P.) Received: 1 September 2020; Accepted: 13 October 2020; Published: 16 October 2020 Abstract: In recent years, huge amounts of antibiotics have been administered to farm animals, and as a result, residues of these antibiotics can accumulate in livestock products and, once consumed, may be transmitted to humans. Farm animals’ antibiotic treatment may therefore present a risk for consumers health, especially for children and adolescents. In children, the immune system is not fully developed, and thus, they are more susceptible than adults to resistant bacteria. A dietary exposure assessment was conducted on veterinary antibiotics found in raw pork meat among children and adolescents in Cyprus, since pork is the most consumed red meat in Cypriot population.
    [Show full text]
  • The Ocean As a Global Reservoir of Antibiotic Resistance Genes
    The Ocean as a Global Reservoir of Antibiotic Resistance Genes Stephen M. Hatosy,a Adam C. Martinya,b Department of Ecology and Evolutionary Biology, University of California, Irvine, California, USAa; Department of Earth System Science, University of California, Irvine, California, USAb Recent studies of natural environments have revealed vast genetic reservoirs of antibiotic resistance (AR) genes. Soil bacteria and Downloaded from human pathogens share AR genes, and AR genes have been discovered in a variety of habitats. However, there is little knowledge about the presence and diversity of AR genes in marine environments and which organisms host AR genes. To address this, we identified the diversity of genes conferring resistance to ampicillin, tetracycline, nitrofurantoin, and sulfadimethoxine in diverse marine environments using functional metagenomics (the cloning and screening of random DNA fragments). Marine environ- ments were host to a diversity of AR-conferring genes. Antibiotic-resistant clones were found at all sites, with 28% of the genes identified as known AR genes (encoding beta-lactamases, bicyclomycin resistance pumps, etc.). However, the majority of AR genes were not previously classified as such but had products similar to proteins such as transport pumps, oxidoreductases, and hydrolases. Furthermore, 44% of the genes conferring antibiotic resistance were found in abundant marine taxa (e.g., Pelagibac- http://aem.asm.org/ ter, Prochlorococcus, and Vibrio). Therefore, we uncovered a previously unknown diversity of genes that conferred an AR pheno- type among marine environments, which makes the ocean a global reservoir of both clinically relevant and potentially novel AR genes. he spread of antibiotic resistance (AR) is critically important sity of marine AR genes, and (iii) are these genes harbored by Tto human health.
    [Show full text]
  • Tetracycline and Sulfonamide Antibiotics in Soils: Presence, Fate and Environmental Risks
    processes Review Tetracycline and Sulfonamide Antibiotics in Soils: Presence, Fate and Environmental Risks Manuel Conde-Cid 1, Avelino Núñez-Delgado 2 , María José Fernández-Sanjurjo 2 , Esperanza Álvarez-Rodríguez 2, David Fernández-Calviño 1,* and Manuel Arias-Estévez 1 1 Soil Science and Agricultural Chemistry, Faculty Sciences, University Vigo, 32004 Ourense, Spain; [email protected] (M.C.-C.); [email protected] (M.A.-E.) 2 Department Soil Science and Agricultural Chemistry, Engineering Polytechnic School, University Santiago de Compostela, 27002 Lugo, Spain; [email protected] (A.N.-D.); [email protected] (M.J.F.-S.); [email protected] (E.Á.-R.) * Correspondence: [email protected] Received: 30 October 2020; Accepted: 13 November 2020; Published: 17 November 2020 Abstract: Veterinary antibiotics are widely used worldwide to treat and prevent infectious diseases, as well as (in countries where allowed) to promote growth and improve feeding efficiency of food-producing animals in livestock activities. Among the different antibiotic classes, tetracyclines and sulfonamides are two of the most used for veterinary proposals. Due to the fact that these compounds are poorly absorbed in the gut of animals, a significant proportion (up to ~90%) of them are excreted unchanged, thus reaching the environment mainly through the application of manures and slurries as fertilizers in agricultural fields. Once in the soil, antibiotics are subjected to a series of physicochemical and biological processes, which depend both on the antibiotic nature and soil characteristics. Adsorption/desorption to soil particles and degradation are the main processes that will affect the persistence, bioavailability, and environmental fate of these pollutants, thus determining their potential impacts and risks on human and ecological health.
    [Show full text]
  • Multi-Residual Quantitative Analytical Method for Antibiotics in Sea Food by LC/MS/MS
    PO-CON1742E Multi-residual quantitative analytical method for antibiotics in sea food by LC/MS/MS ASMS 2017 TP 198 Anant Lohar, Shailendra Rane, Ashutosh Shelar, Shailesh Damale, Rashi Kochhar, Purushottam Sutar, Deepti Bhandarkar, Ajit Datar, Pratap Rasam and Jitendra Kelkar Shimadzu Analytical (India) Pvt. Ltd., 1 A/B, Rushabh Chambers, Makwana Road, Marol, Andheri (E), Mumbai-400059, Maharashtra, India. Multi-residual quantitative analytical method for antibiotics in sea food by LC/MS/MS Introduction Antibiotics are widely used in agriculture as growth LC/MS/MS method has been developed for quantitation of enhancers, disease treatment and control in animal feeding multi-residual antibiotics (Table 1) from sea food sample operations. Concerns for increased antibiotic resistance of using LCMS-8040, a triple quadrupole mass spectrometer microorganisms have prompted research into the from Shimadzu Corporation, Japan. Simultaneous analysis environmental occurrence of these compounds. of multi-residual antibiotics often exhibit peak shape Assessment of the environmental occurrence of antibiotics distortion owing to their different chemical nature. To depends on development of sensitive and selective overcome this, autosampler pre-treatment feature was analytical methods based on new instrumental used [1]. technologies. Table 1. List of antibiotics Sr.No. Name of group Name of compound Number of compounds Flumequine, Oxolinic Acid, Ciprofloxacin, Danofloxacin, Difloxacin.HCl, 1 Fluoroquinolones 8 Enrofloxacin, Sarafloxacin HCl Trihydrate,
    [Show full text]
  • 1. Purpose & Scope the Objective of This Work Instruction Is to Provide
    REVISION: 02 7DENVER LABORATORY WORK INSTRUCTION DOCUMENT NUMBER FOOD AND DRUG ADMINISTRATION DEN-LB-WI-C.009 PAGE 1 OF 47 TITLE: ANALYSIS OF SULFONAMIDES, TRIMETHOPRIM, FLUOROQUINOLONES, ORIGINAL EFFECTIVE DATE: QUINOLONES, TRIPHENYLMETHANE DYES (AND THEIR LEUCO METABOLITES) AND METHYL 03/15/17 TESTOSTERONE IN FISH AND SHRIMP USING LIQUID CHROMATOGRAPHY MASS SPECTROMETRY REVISED: 03 2018 1. Purpose & Scope The objective of this work instruction is to provide instruction on the routine multi-class, multi-residue LC-MS/MS screening of aquaculture samples using components of LIBs 4562 and 4614, and DEN-LAB validation package # 13-37, 15-12, 15-13, 15-15, 15-22, 15-32 & 16-16. 2. Procedure 2.1 Sample Preparation 2.1.1 Aquaculture sample matrices which are appropriate for analysis include but are not limited to: tilapia, eel, swai, pangasius, basa, pompano, red drum, bass, croaker, catfish, trout, salmon, sablefish, scallops, shrimp, and frog legs. 2.1.2 Preparation of homogeneous samples of fish depends on whether skin and/or bones are considered edible for the particular species and product. Skin is removed from species whose skin is considered inedible (e.g., catfish), as are other inedible portions, such as heads, tails, scales, fins, viscera, and inedible bones. 2.1.3 Remove at least 50 g of edible tissue from each of 12 subs. Combine the 600 g tissue in robot coupe with dry ice to homogenize into a fine powder. Note: It is effective to pulse the dry ice block in the robot coupe prior to adding the tissue. 2.1.4 Shrimp sample preparation 2.1.4.1 Thoroughly remove any breading before analysis.
    [Show full text]
  • Transdermal Drug Delivery Device Including An
    (19) TZZ_ZZ¥¥_T (11) EP 1 807 033 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61F 13/02 (2006.01) A61L 15/16 (2006.01) 20.07.2016 Bulletin 2016/29 (86) International application number: (21) Application number: 05815555.7 PCT/US2005/035806 (22) Date of filing: 07.10.2005 (87) International publication number: WO 2006/044206 (27.04.2006 Gazette 2006/17) (54) TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING VORRICHTUNG ZUR TRANSDERMALEN VERABREICHUNG VON ARZNEIMITTELN EINSCHLIESSLICH EINER VERSTOPFUNGSSICHERUNG DISPOSITIF D’ADMINISTRATION TRANSDERMIQUE DE MEDICAMENTS AVEC COUCHE SUPPORT OCCLUSIVE (84) Designated Contracting States: • MANTELLE, Juan AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Miami, FL 33186 (US) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • NGUYEN, Viet SK TR Miami, FL 33176 (US) (30) Priority: 08.10.2004 US 616861 P (74) Representative: Awapatent AB P.O. Box 5117 (43) Date of publication of application: 200 71 Malmö (SE) 18.07.2007 Bulletin 2007/29 (56) References cited: (73) Proprietor: NOVEN PHARMACEUTICALS, INC. WO-A-02/36103 WO-A-97/23205 Miami, FL 33186 (US) WO-A-2005/046600 WO-A-2006/028863 US-A- 4 994 278 US-A- 4 994 278 (72) Inventors: US-A- 5 246 705 US-A- 5 474 783 • KANIOS, David US-A- 5 474 783 US-A1- 2001 051 180 Miami, FL 33196 (US) US-A1- 2002 128 345 US-A1- 2006 034 905 Note: Within nine months of the publication of the mention of the grant of the European patent in the European Patent Bulletin, any person may give notice to the European Patent Office of opposition to that patent, in accordance with the Implementing Regulations.
    [Show full text]
  • A Case Report of Fatal Dapsone-Induced Agranulocytosis in an Indian Mid-Borderline Leprosy Patient
    Lepr Rev <2003) 74, 167±170 CASE REPORT A case report of fatal dapsone-induced agranulocytosis in an Indian mid-borderline leprosy patient RAMESH M. BHAT & K. RADHAKRISHNAN Department of Dermatology, Venereology & Leprosy, Fr. Muller Medical College, Kankanady, Mangalore, Karnataka 575 002, India Accepted for publication 11 February 2003 Summary Fatal agranulocytosis in an Indian male receiving 100 mg of dapsone daily, hospitalized for mid-borderline leprosy in type I reaction with triple nerve paralysis is reported. Various case reports concerning dapsone-induced agranulocytosis are reviewed. Introduction For the last 60 years, dapsone has been used successfully as both an antibacterial and anti- in¯ammatory agent in leprosy and a range of dermatological disorders. Various haematolo- gical adverse effects, including methaemoglobinaemia, haemolysis and fatal agranulocytosis, have been reported.1 Other rare adverse effects such as pulmonary eosinophilia without cutaneous allergic manifestations have also been reported.2 We have also reported dapsone- induced eosinophilia without pulmonary and cutaneous allergic manifestations.3 The ®rst case of dapsone-induced agranulocytosis was reported in 1958 in a patient receiving dapsone for dermatitis herpetiformis.4 In 1970, a report was published concerning 16 US soldiers in Vietnam who developed agranulocytosis after receiving 25 mg of dapsone daily for malaria prophylaxis with a 50% fatality rate.5 Agranulocytosis has also been reported as a complication of weekly maloprim, a combination of
    [Show full text]
  • The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity
    molecules Review The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity Abdul Naeem 1, Syed Lal Badshah 1,2,*, Mairman Muska 1, Nasir Ahmad 2 and Khalid Khan 2 1 National Center of Excellence in Physical Chemistry, University of Peshawar, Peshawar, Khyber Pukhtoonkhwa 25120, Pakistan; [email protected] (A.N.); [email protected] (M.M.) 2 Department of Chemistry, Islamia College University Peshawar, Peshawar, Khyber Pukhtoonkhwa 25120, Pakistan; [email protected] (N.A.); [email protected] (K.K.) * Correspondence: [email protected]; Tel.: +92-331-931-6672 Academic Editor: Peter J. Rutledge Received: 23 December 2015 ; Accepted: 15 February 2016 ; Published: 28 March 2016 Abstract: Quinolones are broad-spectrum synthetic antibacterial drugs first obtained during the synthesis of chloroquine. Nalidixic acid, the prototype of quinolones, first became available for clinical consumption in 1962 and was used mainly for urinary tract infections caused by Escherichia coli and other pathogenic Gram-negative bacteria. Recently, significant work has been carried out to synthesize novel quinolone analogues with enhanced activity and potential usage for the treatment of different bacterial diseases. These novel analogues are made by substitution at different sites—the variation at the C-6 and C-8 positions gives more effective drugs. Substitution of a fluorine atom at the C-6 position produces fluroquinolones, which account for a large proportion of the quinolones in clinical use. Among others, substitution of piperazine or methylpiperazine, pyrrolidinyl and piperidinyl rings also yields effective analogues. A total of twenty six analogues are reported in this review. The targets of quinolones are two bacterial enzymes of the class II topoisomerase family, namely gyrase and topoisomerase IV.
    [Show full text]
  • Belgian Veterinary Surveillance of Antibacterial Consumption National
    Belgian Veterinary Surveillance of Antibacterial Consumption National consumption report 2020 Publication : 22 June 2021 1 SUMMARY This annual BelVet-SAC report is now published for the 12th time and describes the antimicrobial use (AMU) in animals in Belgium in 2020 and the evolution since 2011. For the third year this report combines sales data (collected at the level of the wholesalers-distributors and the compound feed producers) and usage data (collected at farm level). This allows to dig deeper into AMU at species and farm level in Belgium. With a consumption of 87,6 mg antibacterial compounds/kg biomass an increase of +0.2% is seen in 2020 in comparison to 2019. The increase seen in 2020 is spread over both pharmaceuticals (+0.2%) and antibacterial premixes (+4.0%). This unfortunately marks the end of a successful reduction in antibacterial product sales that was seen over the last 6 years resulting in a cumulative reduction of -40,2% since 2011. The gap seen in the coverage of the sales data with the Sanitel-Med collected usage data increased substantially compared to 2019, meaning continuous efforts need to be taken to ensure completeness of the collected usage data. When looking at the evolution in the number of treatment days (BD100) at the species level, as calculated from the SANITEL- MED use data, use increased in poultry (+5,0%) and veal calves (+1,9%), while it decreased in pigs (-3,1%). However, the numerator data for this indicator remain to be updated for 2020, potentially influencing the reliability of the result.
    [Show full text]
  • Sulfadimethoxine Degradation Kinetics in Manure As Affected by Initial Concentration, Moisture, and Temperature
    Published online October 27, 2006 Sulfadimethoxine Degradation Kinetics in Manure as Affected by Initial Concentration, Moisture, and Temperature Q.-Q. Wang, S. A. Bradford, W. Zheng, and S. R. Yates* ABSTRACT However in Europe, a new trend has developed with in- Sulfadimethoxine is a widely used sulfonamide veterinary antibiotic creased therapeutic use of antibiotics (Alder et al., 2001). and could be a source of agricultural contamination. Therefore, infor- After the application to animals, antibiotics will even- mation is needed about its degradation kinetics in manure under aer- tually enter the environment. In fish farming, antibiotics obic conditions. Based on the analysis of first-order kinetics and the are given as feed additives, resulting in a direct release assumption that sulfadimethoxine availability for degradation in ma- of antibiotics into the aquatic environment (Thurman nure could be limiting, a new kinetic model was developed and was et al., 2002). It was estimated that |70 to 80% of drugs found to fit the degradation kinetics well. The degradation rate in administered to fish enters the environment and anti- sterile manure was found to be much lower than in nonsterile manure, biotic residues with significant antibacterial activity were indicating that biodegradation was significant. In biologically active found in the sediment of fish hatcheries (Samuelsen et al., manure, the degradation rate constant decreased with increasing ini- tial concentration of sulfadimethoxine, implying that the activity of 1992). However, the major route through which veteri- the degrading microorganisms was inhibited. Increasing moisture or nary antibiotics enter the environment is the excretion temperature was found to increase sulfadimethoxine degradation in of feces and urine from medicated animals in livestock manure.
    [Show full text]